Fiebeler A[au] - Search Results

Year	Number of Results
1993	1
1994	1
2000	5
2001	6
2002	8
2003	5
2004	7
2005	9
2006	1
2007	5
2008	2
2009	5
2010	4
2011	4
2012	2
2013	1
2024	0

1

The mineralocorticoid receptor and oxidative stress.

Fiebeler A, Luft FC. Fiebeler A, et al. Heart Fail Rev. 2005 Jan;10(1):47-52. doi: 10.1007/s10741-005-2348-y. Heart Fail Rev. 2005. PMID: 15947891 Review.

2

Aldosterone, mineralocorticoid receptors, and vascular inflammation.

Fiebeler A, Muller DN, Shagdarsuren E, Luft FC. Fiebeler A, et al. Curr Opin Nephrol Hypertens. 2007 Mar;16(2):134-42. doi: 10.1097/MNH.0b013e32801245bb. Curr Opin Nephrol Hypertens. 2007. PMID: 17293689 Review.

3

Participation of the mineralocorticoid receptor in cardiac and vascular remodeling.

Fiebeler A, Haller H. Fiebeler A, et al. Nephron Physiol. 2003;94(3):p47-50. doi: 10.1159/000072029. Nephron Physiol. 2003. PMID: 12902615 Review.

4

Angiotensin-induced inflammation and vascular injury.

Müller DN, Dechend R, Fiebeler A, Park JK, Haller H, Luft FC. Müller DN, et al. Among authors: fiebeler a. Contrib Nephrol. 2001;(135):138-52. doi: 10.1159/000060161. Contrib Nephrol. 2001. PMID: 11705279 Review. No abstract available.

5

Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage.

Müller DN, Fiebeler A, Park JK, Dechend R, Luft FC. Müller DN, et al. Among authors: fiebeler a. Clin Nephrol. 2003 Jul;60 Suppl 1:S2-12. Clin Nephrol. 2003. PMID: 12940529 Review.

6

Dehydroepiandrosterone-induced phosphorylation and translocation of FoxO1 depend on the mineralocorticoid receptor.

Lindschau C, Kirsch T, Klinge U, Kolkhof P, Peters I, Fiebeler A. Lindschau C, et al. Among authors: fiebeler a. Hypertension. 2011 Sep;58(3):471-8. doi: 10.1161/HYPERTENSIONAHA.111.171280. Epub 2011 Jul 11. Hypertension. 2011. PMID: 21747041

7

Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene.

Lankisch TO, Vogel A, Eilermann S, Fiebeler A, Krone B, Barut A, Manns MP, Strassburg CP. Lankisch TO, et al. Among authors: fiebeler a. Mol Pharmacol. 2005 May;67(5):1732-9. doi: 10.1124/mol.104.007146. Epub 2005 Feb 16. Mol Pharmacol. 2005. PMID: 15716465

8

Angiotensin-induced inflammation and novel approaches to treatment.

Müller DN, Dechend R, Fiebeler A, Park JK, Haller H, Luft FC. Müller DN, et al. Among authors: fiebeler a. Adv Nephrol Necker Hosp. 2001;31:89-103. Adv Nephrol Necker Hosp. 2001. PMID: 11692473 Review.

9

[Old and new drugs to block aldosterone and ameliorate cardiovascular disease].

Fiebeler A, Luft FC. Fiebeler A, et al. Dtsch Med Wochenschr. 2004 Nov 12;129(46):2491-6. doi: 10.1055/s-2004-835293. Dtsch Med Wochenschr. 2004. PMID: 15536584 Review. German. No abstract available.

10

Complement activation in angiotensin II-induced organ damage.

Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, Dechend R, Gratze P, Luft FC, Muller DN. Shagdarsuren E, et al. Among authors: fiebeler a. Circ Res. 2005 Sep 30;97(7):716-24. doi: 10.1161/01.RES.0000182677.89816.38. Epub 2005 Aug 18. Circ Res. 2005. PMID: 16109917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year